ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
Factors impacting the assessment of geographic atrophy on ultra‑widefield fundus autofluorescence imaging.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo determine how often geographic atrophy (GA) lesions cannot be reliably delineated on ultrawidefield (UWF) green-light fundus autofluorescence (GAF) and to identify factors associated with poor lesion demarcation.
methodsRetrospective cross-sectional study. 88 patients (138 eyes) with GA due to non-exudative age-related macular degeneration (AMD). Consecutive retina clinic subjects with GA secondary to AMD and UWF-GAF, UWF pseudocolor, and OCT imaging at the same visit were included in this study. Eyes with AMD due to other causes, evidence of exudative AMD, or images with overall poor quality were excluded. Two independent masked graders classified the UWF-GAF images as gradable (clearly delineated GA borders amenable to measurement) or ungradable (indistinct borders), and discrepancies were adjudicated by the senior investigator. Choroidal thickness (CT) was measured on central horizontal B-scan at the foveal center and at points 1.5 mm nasal and temporal to the center.
main outcome measuresFrequency of ungradable UWF-GAF images and choroidal thickness measurements at the foveal, nasal, and temporal locations.
resultsUWF-GAF images were deemed ungradable for GA size in 7/138 eyes (5.1%; 95% CI, 2.5-10.1). Inter-reader agreement for gradability was excellent (κ = 0.867; p < 0.001). Ungradable eyes demonstrated a markedly thinner choroid at all measurement locations including the foveal center (74.71 ± 37.04 μm vs. 177.41 ± 91.16 μm; p = 0.0002), nasal (58.14 ± 14.73 μm vs. 132.70 ± 88.28 μm ; p = 0.0013), and temporal (85.29 ± 34.54 μm vs. 177.40 ± 87.07 μm; p = 0.018) points.
conclusionIn retina practices that routinely obtain Optos UWF-GAF imaging, approximately 5% of GA lesions may not be measurable on UWF GAF imaging, with a very thin choroid being a common feature among such cases. Green fluorescence from the unmasked sclera is the likely explanation for this phenomenon, though such GA lesions lend themselves to reliable quantification using the companion UWF pseudocolor image. These findings have implications for the monitoring of GA lesions in clinical practice in the era of GA therapeutics.
Indexed as
Identifiers
42270914What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.